 |
|
|
|||||
Sun Pharma faces potential impact from the US 100% tariff on patented drugs, which could reduce FY2627 earnings by 810%. Generic drugs remain exempt. The companys innovative portfolio, strong cash position, and mitigation options support steady revenue growth, maintaining HSBCs Buy rating with Rs 1,850 target.
Category:
News and Media
Spirit maker Alcobrew Distilleries India Ltd has filed draft papers with capital markets regulator Sebi to seek its approval to raise funds through an initial public offering (IPO).
Category:
News and Media
The combined market valuation of the top-10 most valued firms eroded by Rs 2,99,661.36 crore last week, in line with a bearish trend in equities, with IT bellwether Tata Consultancy Services taking the biggest hit.
Category:
News and Media
Tata Capital plans Indias largest 2025 IPO of Rs 17,200 crore on October 6. Proceeds will boost Tier-1 capital, supporting lending growth. Grey market trades at Rs 29; valuation ~$18 billion.
Category:
News and Media
HSBC reiterates Buy on Eternal, raising its target to Rs 390, citing strong scale, margin leadership, and robust cash reserves. Swiggy remains on Hold due to slower margin growth, high cash burn, and execution risks, despite rising average order values. Eternal outperforms in quick commerce and food delivery segments.
Category:
News and Media
Sites : [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] next »